This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

ARIAD Pharmaceuticals Inc
ARIA : NASDAQ : Health Care
$6.12 0.51 | 9.09%
Today's Range: 5.60 - 6.14
Avg. Daily Volume: 8,659,500
07/29/14 - 1:25 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
ARIA ARIAD PHARMACEUTICALS INC 6.18 1154.97 n/m 50.88 633.02
KERX KERYX BIOPHARMACEUTICALS INC 14.86 1358.99 n/m 10.00 42.85
CLDX CELLDEX THERAPEUTICS INC 14.07 1257.27 n/m 2.11 -81.11
CLVS CLOVIS ONCOLOGY INC 37.01 1255.08 n/m 13.63 n/a
ACOR ACORDA THERAPEUTICS INC 29.56 1233.63 67.18 345.08 12.61
DYAX DYAX CORP 9.04 1227.64 n/m 56.00 1.45
HALO HALOZYME THERAPEUTICS INC 9.20 1145.48 n/m 54.93 17.57
CBPO CHINA BIOLOGIC PRODUCTS INC 46.07 1115.77 21.83 205.59 7.29
EPZM EPIZYME INC 33.47 1109.70 n/m 72.99 721.78
ARNA ARENA PHARMACEUTICALS INC 4.85 1065.30 n/m 85.84 209.08
LGND LIGAND PHARMACEUTICAL INC 51.08 1058.63 n/a 54.30 31.66
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

ARIA Ind Avg S&P 500
n/m 80.07 19.71

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs